imdevimab
monoclonal antibody against SARS-CoV-2 developed by Regeneron
Press Enter · cited answer in seconds
0 sources
imdevimab
Summary
imdevimab is a monoclonal antibody[1].
Key Facts
- imdevimab's instance of is recorded as monoclonal antibody[2].
- imdevimab's developer is recorded as Regeneron Pharmaceuticals[3].
- imdevimab's CAS Registry Number is recorded as 2415933-40-1[4].
- imdevimab's part of is recorded as casirivimab/imdevimab[5].
- imdevimab's Commons category is recorded as Imdevimab[6].
- imdevimab's UNII is recorded as 2Z3DQD2JHM[7].
- imdevimab's DrugBank ID is recorded as DB15940[8].
- imdevimab's name is recorded as REGN10987[9].
- imdevimab's Google Knowledge Graph ID is recorded as /g/11qnt9jzdx[10].
- imdevimab's RxNorm CUI is recorded as 2465249[11].